24 results
8-K
EX-99.1
NUVL
Nuvalent Inc - Ordinary Shares
27 Feb 24
Nuvalent Highlights Pipeline Progress, Reiterates Key Anticipated Milestones and Reports Fourth Quarter and Full Year 2023 Financial Results
6:38am
culture centered around our core values of Patient Impact, Empowerment, and Collaboration. In recognition of his leadership and contributions across …
The company expects to initiate the Phase 1 trial for its HER2 program in 2024.
Recent Leadership Promotions
Promotion of Matthew Metivier to Senior Vice
8-K
EX-99.1
hkgccfxz 2l
14 Nov 23
Nuvalent Highlights Corporate and Pipeline Achievements and Reports Third Quarter
6:45am
PRE 14A
w0wwz8kiesph9kp2
13 Apr 23
Preliminary proxy
4:30pm
8-K
EX-99.1
3d6xlt6kyr
12 May 22
Nuvalent Highlights Pipeline and Business Progress and Reports First Quarter 2022 Financial Results
6:45am
DEF 14A
darabl5vpfynx sh9nnn
29 Apr 22
Definitive proxy
4:07pm
10-K
hefjrsob
29 Mar 22
Annual report
7:21am
10-Q
60evc0u62
8 Sep 21
Quarterly report
8:31am
8-K
EX-99.1
al5sf
8 Sep 21
Nuvalent Announces Business and Program Highlights and Reports Second Quarter 2021 Financial Results
6:35am
424B4
xs7 fj1poksjthxkfrj
30 Jul 21
Prospectus supplement with pricing info
4:06pm